Compare

Synopsys/$SNPS

1D1W1M3M6MYTD1Y5YMAX

About Synopsys

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Ticker
$SNPS
Sector
Software & Cloud Services
Primary listing
NASDAQ
Employees
28,000

Synopsys Metrics

BasicAdvanced
$83B
76.41
$5.64
1.18
-

What the Analysts think about Synopsys

Analyst ratings (Buy, Hold, Sell) for Synopsys stock.
Analyst projections of the future price of Synopsys stock.

Bulls say / Bears say

Synopsys beat its third-quarter guidance and raised its 2026 revenue and earnings outlook, pointing to improving execution across the business. (Synopsys)
Demand for chip-design tools is benefiting from AI investment and the growing complexity of advanced chips. Reuters also reported that major technology companies are stepping up in-house chip programmes, creating another source of demand for Synopsys. (Reuters)
The Ansys combination could create new growth through integrated chip-design and simulation products. Synopsys says its Multiphysics Fusion solution has been validated by customers and is expected to start contributing to EDA growth in 2027. (The Motley Fool)
Synopsys’ 2026 outlook assumes no further changes to export controls. Tighter restrictions could limit sales or delay customer work, particularly in China. (Synopsys)
The Ansys acquisition leaves Synopsys with roughly $10 billion of debt, while the company still needs to deliver the deal’s expected benefits. That debt and integration burden could constrain flexibility if growth or synergies disappoint. (Investing.com, Synopsys)
An August analysis put Synopsys’ price-to-earnings ratio at 77.5, leaving the shares exposed to a sharp re-rating if growth falls short of expectations. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 28 Oct 2026.

Synopsys Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Synopsys Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise

Funds containing Synopsys

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.